PDS Biotechnology Reports Financial Results for the Second Quarter 2020 and Provides Business Update

NEXT STORY
RedHill Biopharma and Cosmo Pharmaceuticals to Expand Strategic Partnership with Exclusive Licensing Agreement and Manufacturing Agreement for Multiple Products
PREV STORY
Sorrento to Take Action Against Hindenburg Research for Statements Believed Intended to Manipulate Stock Price
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

SpringWorks Therapeutics Announces Clinical Collaboration with Janssen to Evaluate Nirogacestat in Combination with Teclistamab in Patients with Relapsed or Refractory Multiple Myeloma

author_avatar
NASDAQ Market News

Dynavax Technologies to Report First Quarter 2019 Financial Results and Host Conference Call on May 8

author_avatar
NASDAQ Market News

FIT Biotech Oy: Conversion of FIT Biotech Oy’s Convertible Capital Notes into shares

FIT Biotech Oy Company release May 25, 2018 at 3:30 PM EET Conversion of ...

author_avatar
NASDAQ Market News